Position in MYGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,632,114
-$243,476 QoQ
Shares Held
362,692
+18.9% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Derivatives in MYGN
reported options exposure · as of Mar 31, 2024CallValue
$2,132
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $1,382,552,556 across 39 Diagnostics & Research names. MYGN ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
665,128 | $326,930,365 | |
| 2 | DHR |
Danaher Corp /De/
|
1,376,341 | $260,954,253 | |
| 3 | A |
Agilent Technologies, Inc.
|
1,417,666 | $161,585,570 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
66,634 | $84,038,800 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
138,726 | $77,948,752 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
392,886 | $67,002,778 | |
| 7 | DGX |
Quest Diagnostics Inc
|
270,281 | $52,969,670 | |
| 8 | GH |
Guardant Health, Inc.
|
572,650 | $52,895,680 |
All Filings in MYGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,632,114 | 362,692 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,875,590 | 304,974 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,781,287 | 384,687 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,375,348 | 259,011 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,049,365 | 118,305 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $948,498 | 69,183 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,253,777 | 45,775 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,221,287 | 49,930 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,132 | 100 | Call | Defined | 2024-05-01 | |
| 2024-03-31 | $1,590,045 | 74,580 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,722,772 | 90,009 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $669,365 | 41,731 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,145,764 | 49,429 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $2,401,749 | 103,390 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $756,885 | 52,163 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $480,905 | 26,467 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $735,688 | 29,194 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $1,507,539 | 54,621 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,965,190 | 91,830 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,513,159 | 49,482 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,212,975 | 39,835 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $444,528 | 22,485 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $234,824 | 18,008 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $149,642 | 13,196 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $651,062 | 45,497 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||